← brief for 2026-08-14 · Slowing decline
Case Report: Efficacy and safety of SGLT2 inhibitors in patients with Alström syndrome: a follow-up report of two siblings from the same family.
Key takeaways
This study used cell models of Alström syndrome to test drug safety. It was not done in humans yet.
Who did this work
Xue B · Li K · Guo Y · Wu Y · Peng H · Fu L · Jiang H
Source
Article · PubMed, the drug frontier · 2026 Jul 30
https://pubmed.ncbi.nlm.nih.gov/42597194/